ALUNBRIG: payments to doctors
Payments that named ALUNBRIG as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $3.2M
- Providers
- 4,551
- Transactions
- 10,181
- Average per transaction
- $314
The per-transaction average — $314 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4,551 providers the average total is $703, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $3,196,991 | 99.9% |
| Takeda Pharmaceutical Company, Limited | $2,802 | 0.1% |